OP 30
Gastroenteropancreatic neuroendocrine carcinoma: single center experience
Lido
1846
Vezesque se leu este artigo
962
Total PDF
884
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 19 | 5 | 24 |
| 2025 5 | 43 | 15 | 58 |
| 2025 4 | 39 | 12 | 51 |
| 2025 3 | 37 | 10 | 47 |
| 2025 2 | 29 | 21 | 50 |
| 2025 1 | 30 | 25 | 55 |
| 2024 12 | 26 | 12 | 38 |
| 2024 11 | 25 | 11 | 36 |
| 2024 10 | 17 | 11 | 28 |
| 2024 9 | 21 | 17 | 38 |
| 2024 8 | 21 | 17 | 38 |
| 2024 7 | 18 | 16 | 34 |
| 2024 6 | 21 | 20 | 41 |
| 2024 5 | 19 | 26 | 45 |
| 2024 4 | 19 | 22 | 41 |
| 2024 3 | 18 | 17 | 35 |
| 2024 2 | 16 | 16 | 32 |
| 2024 1 | 15 | 22 | 37 |
| 2023 12 | 17 | 30 | 47 |
| 2023 11 | 32 | 39 | 71 |
| 2023 10 | 14 | 18 | 32 |
| 2023 9 | 15 | 30 | 45 |
| 2023 8 | 7 | 8 | 15 |
| 2023 7 | 14 | 5 | 19 |
| 2023 6 | 13 | 19 | 32 |
| 2023 5 | 17 | 15 | 32 |
| 2023 4 | 10 | 3 | 13 |
| 2023 3 | 10 | 12 | 22 |
| 2023 2 | 10 | 8 | 18 |
| 2023 1 | 8 | 7 | 15 |
| 2022 12 | 9 | 12 | 21 |
| 2022 11 | 15 | 15 | 30 |
| 2022 10 | 12 | 12 | 24 |
| 2022 9 | 13 | 19 | 32 |
| 2022 8 | 9 | 11 | 20 |
| 2022 7 | 9 | 22 | 31 |
| 2022 6 | 8 | 15 | 23 |
| 2022 5 | 11 | 19 | 30 |
| 2022 4 | 7 | 17 | 24 |
| 2022 3 | 11 | 17 | 28 |
| 2022 2 | 10 | 19 | 29 |
| 2021 1 | 9 | 8 | 17 |
| 2021 12 | 9 | 18 | 27 |
| 2021 11 | 9 | 20 | 29 |
| 2021 10 | 11 | 26 | 37 |
| 2021 9 | 11 | 20 | 31 |
| 2021 8 | 12 | 31 | 43 |
| 2021 7 | 11 | 20 | 31 |
| 2021 6 | 12 | 19 | 31 |
| 2021 5 | 19 | 33 | 52 |
| 2021 4 | 12 | 32 | 44 |
| 2021 3 | 22 | 20 | 42 |
| 2021 2 | 12 | 13 | 25 |
| 2020 1 | 9 | 16 | 25 |
| 2020 12 | 7 | 8 | 15 |
| 2020 11 | 5 | 11 | 16 |
Mostrar tudo
